Synthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors

ArticleAçık Erişim

Özet

Eleven new thiosemicarbazone derivatives (1–11) were designed from nine different biologically and pharmacologically important isothiocyanate derivatives containing functional groups such as fluorine, chlorine, methoxy, methyl, and nitro at various positions of the phenyl ring, in addition to the benzyl unit in the molecular skeletal structure. First, their substituted-thiosemicarbazide derivatives were synthesized from the treatment of isothiocyanate with hydrazine to synthesize the designed compounds. Through a one-step easy synthesis and an eco-friendly process, the designed compounds were synthesized with yields of up to 95 % from the treatment of the thiosemicarbazides with aldehyde derivatives having methoxy and hydroxy groups. The structures of the synthesized molecules were elucidated with elemental analysis and FT–IR, 1H-NMR, and 13C-NMR spectroscopic methods. The electronic and spectroscopic properties of the compounds were determined by the DFT calculations performed at the B3LYP/6-311++G(2d,2p) level of theory, and the experimental findings were supported. The effects of some global reactivity parameters and nucleophilic-electrophilic attack abilities of the compounds on the enzyme inhibition properties were also investigated. They exhibited a highly potent inhibition effect on acetylcholinesterase (AChE) and carbonic anhydrases (hCAs) (KI values are in the range of 23.54±4.34 to 185.90±26.16 nM, 103.90±23.49 to 325.90±77.99 nM, and 86.15±18.58 to 287.70±43.09 nM for AChE, hCA I, and hCA II, respectively). Furthermore, molecular docking simulations were performed to explain each enzyme-ligand complex's interaction. © 2023 Wiley-VHCA AG, Zurich, Switzerland.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11870Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1002/cbdv.202301063Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorErdoğan, Musa
dc.contributor.authorSerdar Çavuş, M.
dc.contributor.authorMuğlu, Halit
dc.contributor.authorYakan, Hasan
dc.contributor.authorTürkeş, Cüneyt
dc.contributor.authorDemir, Yeliz
dc.contributor.authorBeydemir, Şükrü
dc.date.accessioned2026-10-18T20:26:51.737265265Z
dc.date.available2026-10-18T20:26:51.737265265Z
dc.date.issued2023
dc.description.abstractEleven new thiosemicarbazone derivatives (1–11) were designed from nine different biologically and pharmacologically important isothiocyanate derivatives containing functional groups such as fluorine, chlorine, methoxy, methyl, and nitro at various positions of the phenyl ring, in addition to the benzyl unit in the molecular skeletal structure. First, their substituted-thiosemicarbazide derivatives were synthesized from the treatment of isothiocyanate with hydrazine to synthesize the designed compounds. Through a one-step easy synthesis and an eco-friendly process, the designed compounds were synthesized with yields of up to 95 % from the treatment of the thiosemicarbazides with aldehyde derivatives having methoxy and hydroxy groups. The structures of the synthesized molecules were elucidated with elemental analysis and FT–IR, 1H-NMR, and 13C-NMR spectroscopic methods. The electronic and spectroscopic properties of the compounds were determined by the DFT calculations performed at the B3LYP/6-311++G(2d,2p) level of theory, and the experimental findings were supported. The effects of some global reactivity parameters and nucleophilic-electrophilic attack abilities of the compounds on the enzyme inhibition properties were also investigated. They exhibited a highly potent inhibition effect on acetylcholinesterase (AChE) and carbonic anhydrases (hCAs) (KI values are in the range of 23.54±4.34 to 185.90±26.16 nM, 103.90±23.49 to 325.90±77.99 nM, and 86.15±18.58 to 287.70±43.09 nM for AChE, hCA I, and hCA II, respectively). Furthermore, molecular docking simulations were performed to explain each enzyme-ligand complex's interaction. © 2023 Wiley-VHCA AG, Zurich, Switzerland.
dc.description.sponsorshipFunding text 1: This work was supported by the Research Fund of Anadolu University (grant number 2102 S003). The DFT calculations reported in this article were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources). ; Funding text 2: This work was supported by the Research Fund of Anadolu University (grant number 2102 S003). The DFT calculations reported in this article were partially performed at TUBITAK ULAKBIM, High Performance and Grid Computing Center (TRUBA resources).
dc.identifier.doi10.1002/cbdv.202301063
dc.identifier.issn1612-1872
dc.identifier.issue11
dc.identifier.pmid37769192
dc.identifier.scopus2-s2.0-85174602710
dc.identifier.startpagee202301063
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11870
dc.identifier.volume20
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofChemistry and Biodiversity
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDFT
dc.subjectenzyme inhibition
dc.subjectmolecular docking
dc.subjectstructure characterization
dc.subjectthiosemicarbazones
dc.subjectacetylcholinesterase
dc.subjectaldehyde derivative
dc.subjectcarbonate dehydratase I
dc.subjectcarbonate dehydratase II
dc.subjectcarbonate dehydratase inhibitor
dc.subjectchlorine
dc.subjectcholinesterase inhibitor
dc.subjectfluorine
dc.subjectglyceryl trinitrate
dc.subjecthydrazine
dc.subjecthydroxyl group
dc.subjectisothiocyanic acid
dc.subjectisothiocyanic acid derivative
dc.subjectthiosemicarbazide derivative
dc.subjectArticle
dc.subjectcarbon nuclear magnetic resonance
dc.subjectcomputer model
dc.subjectcontrolled study
dc.subjectdensity functional theory
dc.subjectdrug design
dc.subjectdrug screening
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectelectrophilicity
dc.subjectelemental analysis
dc.titleSynthesis, Theoretical, in Silico and in Vitro Biological Evaluation Studies of New Thiosemicarbazones as Enzyme Inhibitors
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus13
rdl.departmentDepartment of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, 24002, Erzincan, Turkey.
rdl.oa.statusopen
rdl.source.indexSCOPUS
rdl.source.indexPUBMED